CUPRITE 3 SPECIAL ORDER- cuprite 3 special order powder 
Uriel Pharmacy Inc.

Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

----------

Cuprite 3 Special Order

Directions: FOR ORAL USE ONLY.

Ages 12 and older: 1/8 teaspoon. Ages 2-11: 1/16 teaspoon. Under age 2: Consult a doctor.

Active Ingredient: Cuprite 3X

Inactive Ingredient: Lactose

Use: Temporary relief of headache.

KEEP OUT OF REACH OF CHILDREN.

Warnings: Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Do not use if allergic to any ingredient. Contains lactose. Consult a doctor before use for serious conditions or if conditions worsen or persist. If pregnant or nursing, consult a doctor before use. Do not use if safety seal is broken or mssing.

Questions? Call 866.642.2858 Uriel, East Troy, WI 53120 www.urielpharmacy.com

Cuprite3SOPowder

CUPRITE 3 SPECIAL ORDER 
cuprite 3 special order powder
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:48951-3137
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CUPRIC OXIDE (UNII: V1XJQ704R4) (CUPRIC CATION - UNII:8CBV67279L) CUPRIC CATION3 [hp_X]  in 1 g
Inactive Ingredients
Ingredient NameStrength
LACTOSE (UNII: J2B2A4N98G)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:48951-3137-460 g in 1 BOTTLE, GLASS; Type 0: Not a Combination Product09/01/2009
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved homeopathic09/01/2009
Labeler - Uriel Pharmacy Inc. (043471163)
Establishment
NameAddressID/FEIBusiness Operations
Uriel Pharmacy Inc.043471163manufacture(48951-3137)

Revised: 4/2018
Document Id: 6aade953-e8cb-765b-e053-2a91aa0a20af
Set id: 3b5f133f-f0cb-4e99-8092-eb8822daf7cb
Version: 2
Effective Time: 20180425
 
Uriel Pharmacy Inc.